FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and medicine, particularly it is used for treating various forms and localisation of tuberculosis.
EFFECT: medicine under the present invention containing sodium aminosalicylate and dextran, and provides the effective treatment of multidrug-resistant pulmonary tuberculosis.
3 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICATION FOR TUBERCULOSIS TREATMENT | 2009 |
|
RU2405554C1 |
| ANTITUBERCULOUS DRUG | 2009 |
|
RU2466722C2 |
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2009 |
|
RU2424808C2 |
| COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
| COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
| ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION FOR PARENTERAL USE IN SMALL DOSAGES VOLUME | 2014 |
|
RU2578433C1 |
| COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
| ANTITUBERCULOUS DRUG AND METHOD OF TREATING | 2010 |
|
RU2449797C1 |
| METHOD FOR PREPARING WATER-SOLUBLE CHITOSAN PARA-AMINOSALICYLATE | 2010 |
|
RU2440111C1 |
| COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2417087C2 |
Authors
Dates
2013-07-20—Published
2009-05-12—Filed